XML 22 R73.htm IDEA: XBRL DOCUMENT v3.3.0.814
Guarantor and Non-Guarantor Financial Statements, Comprehensive Income Statements (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME        
Net sales $ 336.4 $ 338.9 $ 1,075.3 $ 1,018.1
Cost of products sold:        
Cost of products sold, excluding depreciation and amortization and other items 267.3 280.4 864.4 838.8
Unrealized losses on derivative instruments 1.7 3.6 7.7 0.0
Depreciation and amortization 8.1 8.0 24.2 23.1
Selling, general, administrative, research and development 21.1 19.0 67.4 61.3
Net periodic postretirement benefit cost relating to Salaried VEBA 0.6 (6.0) 1.8 (17.7)
Gain on removal of Union VEBA net assets (2.9) 0.0 490.9 0.0
Total selling, general, administrative, research and development 18.8 13.0 560.1 43.6
Total costs and expenses 295.9 306.3 1,456.4 907.0
Other operating charges, net 0.0 1.3 0.0 1.5
Operating (loss) income 40.5 32.6 (381.1) 111.1
Other (expense) income:        
Interest expense (4.9) (9.7) (19.9) (27.7)
Other income (expense), net (0.9) 2.2 (0.1) 5.9
(Loss) income before income taxes 34.7 25.1 (401.1) 89.3
Income tax (provision) benefit (12.6) (9.2) 151.2 (33.1)
Earnings in equity of subsidiaries 0.0 0.0 0.0 0.0
Net income 22.1 15.9 (249.9) 56.2
Comprehensive income 22.2 17.2 (182.5) 60.5
Parent        
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME        
Net sales 0.0 0.0 0.0 0.0
Cost of products sold:        
Cost of products sold, excluding depreciation and amortization and other items 0.0 0.0 0.0 0.0
Unrealized losses on derivative instruments 0.0 0.0 0.0 0.0
Depreciation and amortization 0.0 0.0 0.0 0.0
Selling, general, administrative, research and development 0.9 0.9 3.3 3.1
Net periodic postretirement benefit cost relating to Salaried VEBA 0.0 0.0 0.0 0.0
Gain on removal of Union VEBA net assets 0.0   0.0  
Total selling, general, administrative, research and development 0.9 0.9 3.3 3.1
Total costs and expenses 0.9 0.9 3.3 3.1
Other operating charges, net   0.0   0.0
Operating (loss) income (0.9) (0.9) (3.3) (3.1)
Other (expense) income:        
Interest expense (4.7) (9.4) (19.1) (28.0)
Other income (expense), net (0.6) 2.2 (0.6) 3.6
(Loss) income before income taxes (6.2) (8.1) (23.0) (27.5)
Income tax (provision) benefit 0.0 0.0 0.0 0.0
Earnings in equity of subsidiaries 28.3 24.0 (226.9) 83.7
Net income 22.1 15.9 (249.9) 56.2
Comprehensive income 22.2 17.2 (182.5) 60.5
Guarantor Subsidiaries        
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME        
Net sales 329.5 330.3 1,051.2 993.1
Cost of products sold:        
Cost of products sold, excluding depreciation and amortization and other items 263.1 274.7 848.9 824.4
Unrealized losses on derivative instruments 1.7 3.6 7.7 0.0
Depreciation and amortization 7.8 7.7 23.3 22.3
Selling, general, administrative, research and development 18.4 17.2 58.6 52.3
Net periodic postretirement benefit cost relating to Salaried VEBA 0.6 (6.0) 1.8 (17.7)
Gain on removal of Union VEBA net assets (2.9)   490.9  
Total selling, general, administrative, research and development 16.1 11.2 551.3 34.6
Total costs and expenses 288.7 298.5 1,431.2 882.8
Other operating charges, net   1.3   1.5
Operating (loss) income 40.8 31.8 (380.0) 110.3
Other (expense) income:        
Interest expense (0.3) (0.5) (1.1) (0.1)
Other income (expense), net 2.2 0.3 3.0 2.3
(Loss) income before income taxes 42.7 31.6 (378.1) 112.5
Income tax (provision) benefit (15.6) (11.9) 140.5 (42.3)
Earnings in equity of subsidiaries (1.0) 1.6 2.2 3.4
Net income 26.1 21.3 (235.4) 73.6
Comprehensive income 26.5 22.5 (167.8) 77.7
Non-Guarantor Subsidiaries        
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME        
Net sales 29.4 33.6 97.6 100.7
Cost of products sold:        
Cost of products sold, excluding depreciation and amortization and other items 25.3 29.8 85.8 87.9
Unrealized losses on derivative instruments 0.0 0.0 0.0 0.0
Depreciation and amortization 0.3 0.3 0.9 0.8
Selling, general, administrative, research and development 2.4 1.7 7.2 7.9
Net periodic postretirement benefit cost relating to Salaried VEBA 0.0 0.0 0.0 0.0
Gain on removal of Union VEBA net assets 0.0   0.0  
Total selling, general, administrative, research and development 2.4 1.7 7.2 7.9
Total costs and expenses 28.0 31.8 93.9 96.6
Other operating charges, net   0.0   0.0
Operating (loss) income 1.4 1.8 3.7 4.1
Other (expense) income:        
Interest expense 0.0 0.0 0.0 0.0
Other income (expense), net (2.4) (0.1) (2.2) 0.4
(Loss) income before income taxes (1.0) 1.7 1.5 4.5
Income tax (provision) benefit 0.8 (0.1) 2.2 (0.9)
Earnings in equity of subsidiaries 0.0 0.0 0.0 0.0
Net income (0.2) 1.6 3.7 3.6
Comprehensive income (0.5) 1.7 3.5 3.8
Consolidating Adjustments        
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME        
Net sales (22.5) (25.0) (73.5) (75.7)
Cost of products sold:        
Cost of products sold, excluding depreciation and amortization and other items (21.1) (24.1) (70.3) (73.5)
Unrealized losses on derivative instruments 0.0 0.0 0.0 0.0
Depreciation and amortization 0.0 0.0 0.0 0.0
Selling, general, administrative, research and development (0.6) (0.8) (1.7) (2.0)
Net periodic postretirement benefit cost relating to Salaried VEBA 0.0 0.0 0.0 0.0
Gain on removal of Union VEBA net assets 0.0   0.0  
Total selling, general, administrative, research and development (0.6) (0.8) (1.7) (2.0)
Total costs and expenses (21.7) (24.9) (72.0) (75.5)
Other operating charges, net   0.0   0.0
Operating (loss) income (0.8) (0.1) (1.5) (0.2)
Other (expense) income:        
Interest expense 0.1 0.2 0.3 0.4
Other income (expense), net (0.1) (0.2) (0.3) (0.4)
(Loss) income before income taxes (0.8) (0.1) (1.5) (0.2)
Income tax (provision) benefit 2.2 2.8 8.5 10.1
Earnings in equity of subsidiaries (27.3) (25.6) 224.7 (87.1)
Net income (25.9) (22.9) 231.7 (77.2)
Comprehensive income $ (26.0) $ (24.2) $ 164.3 $ (81.5)